4//SEC Filing
Hagan Joseph P 4
Accession 0000950170-25-005883
CIK 0001505512other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 5:00 PM ET
Size
6.9 KB
Accession
0000950170-25-005883
Insider Transaction Report
Form 4
Hagan Joseph P
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-01-13$1.26/sh−115,290$145,634→ 222,572 total - Sale
Common Stock
2025-01-14$1.26/sh−11,764$14,860→ 210,808 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) which commenced vesting on January 9, 2025. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.
- [F2]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) which commenced vesting on January 12, 2024. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001465278
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 5:00 PM ET
- Size
- 6.9 KB